Photomedicine Technology Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||661012|
|出版日期||內容資訊||英文 115 Pages
|光醫學技術的全球市場:各應用、技術、地理的成長，趨勢及預測(2018年∼2023年) Photomedicine Technology Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年05月01日||內容資訊: 英文 115 Pages||
The global photomedicine technology market is expected to register a CAGR of 5.2% during the forecast period of 2019-2024. Increasing adoption of advanced, laser-based treatments are fueling market growth. According to the most recent statistics from the American Society for Aesthetic Plastic Surgery (ASAPS), laser hair removal treatments were the third most popular non-surgical cosmetic procedure in 2017. According to the data published by the American Society for Aesthetic Plastic Surgery, about 31,892 laser skin resurfacing procedures and 178,488 laser or pulsed light hair removal procedures were undertaken in the United States in 2017. Increasing awareness about non-invasive procedures, advancements in laser delivery procedures, and rising demand for cosmetic surgeries are contributing to the expanding adoption of advanced laser-based therapies, which, in turn, is expected to fuel the growth of the global photomedicine technology market during the forecast period.
As per the scope of this report, photomedicine is a branch of medicine that deals with the application of light with respect to health and disease. This report on the photomedicine market includes the range of products and services being used by (but not limited to) hospitals, clinics, organization, and individuals for healthcare therapies.
Oncology Segment is Expected to Register Significant Growth
Phototherapy is one of the most successful therapies used for curing cancer. In a process called photodynamic therapy (PDT), light-sensitive drugs are injected into the body, which settles into the cancer cells. When the cells are exposed to certain light waves, the drugs are activated to kill the cells and shrink the tumor. US FDA approved the photosensitizing agent called porfimer sodium, or photofrin, for use in PDT, to treat or relieve the symptoms of esophageal cancer and non-small cell lung cancer. The porfimer sodium itself can destroy the blood vessels in the tumor. When the tumor does not receive enough blood, basically, it starves to death. This is one of the successful molecules used mostly for esophageal cancer. Aminolevulinic acid is one of the recent drugs identified to treat actinic keratosis (AK), a skin condition that can become cancer; however, it can only be used on the face or scalp. A special blue light, rather than the laser light, is used to activate this drug. Owing to the increasing prevalence of cancer coupled with the increasing trend of early detection and therapeutic intervention, novel therapeutic approaches such as phototherapies are increasingly being employed.
North America is Expected to Retain Largest Market Share During the Period of Forecast.
North America dominated the market with the largest revenue share in 2016. Availability of advanced diagnostic tools and high awareness regarding these products are the key factors driving the growth of the market in North America. The accelerated growth in the Canadian market can be attributed to the initiatives of the government and non-government organizations. For instance, the Public Health Agency of Canada organized the World Hepatitis Day in order to increase awareness regarding hepatitis detection. Thereby, leading to the demand for hepatitis detection in the country.
Several global and local companies are operating in the market. The market is observing significant technological shifts and market participants are competing on the basis of product advancements such as increased efficacy and ease of operation. Key players in the market include Alma Lasers, Beurer GmbH, Biolitec AG, Koninklijke Philips N.V., Lumenis, Photomedex, Inc., Quantel Medical, Inc., Syneron Candela, Thor Photomedicine Ltd, and Verilux, Inc.